help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latronico, A. C.
Right arrow Articles by Mendonca, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latronico, A. C.
Right arrow Articles by Mendonca, B. B.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 7 2435-2440
Copyright © 1998 by The Endocrine Society


Original Studies

A Unique Constitutively Activating Mutation in Third Transmembrane Helix of Luteinizing Hormone Receptor Causes Sporadic Male Gonadotropin-Independent Precocious Puberty1

A. C. Latronico, A. N. Abell, I. J. P. Arnhold, X. Liu, T. S. S. Lins, V. N. Brito, A. E. Billerbeck, D. L. Segaloff2 and B. B. Mendonca

Department of Physiology and Biophysics, The University of Iowa College of Medicine (A.N.A., X.L., D.L.S.), Iowa City, Iowa; Instituto Materno Infantil de Pernambuco (T.S.S.L.), Recife, Brazil; and Developmental Endocrinology Unit, Hospital das Clínicas, São Paulo University, Medical School (A.C.L., I.J.P.A., V.N.B. A.E.B., B.B.M), São Paulo, Brazil

Address all correspondence and requests for reprints to: Ana Claudia Latronico, Hospital das Clínicas, Disciplina de Endocrinologia, Universidade de São Paulo, Caixa Postal: 3671, São Paulo, CEP 01060–970, Brazil. E-mail: anacl{at}usp.br

Several constitutively activating mutations have been demonstrated in the sixth transmembrane helix of the human LH receptor (hLHR) in boys with gonadotropin-independent precocious puberty. In the current study, we examined two unrelated Brazilian boys with gonadotropin-independent precocious puberty caused by two different heterozygous activating mutations of the hLHR. Direct sequencing of the entire exon 11 of the hLHR revealed a heterozygous substitution of T for G at nucleotide 1370, that converts Leu 457 to Arg in the third transmembrane helix of the hLHR in one affected boy. His biological parents had a normal hLHR gene sequence, establishing the sporadic nature of this novel Leu457Arg mutation. Human embryonic 293 cells expressing hLHR mutant (L457R) or hLHR wild-type bound CG with high affinity. However, cells expressing hLHR(L457R) exhibited significantly higher basal levels of cAMP (7- to 14-fold) than cells expressing the wild-type receptor, indicating constitutive activation of hLHR(L457R). Basal levels of cAMP in hLHR(L457R)-expressing cells were, nonetheless, not as great as the levels of cAMP produced by hLHR wild-type-expressing cells incubated with a saturating concentration of CG. Furthermore, cells expressing hLHR(L457R) were unresponsive to further stimulation by CG. This finding was confirmed in the patient by lack of an increase in serum testosterone after CG stimulation. These results suggest that the conformation of hLHR(L457R) mutant represents a different activated receptor state (R*) than the agonist-occupied wild-type receptor. We also identified the previously described Ala568Val mutation in the third intracellular loop of the LHR in the other affected African-Brazilian boy and his normal prepubertal sister, suggesting the inherited form of precocious puberty in this boy. We conclude that the third transmembrane helix is a potential area for activating mutations of the hLHR that cause male precocious puberty.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff
Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations
J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
P. Nurwakagari, A. Breit, C. Hess, H. Salman-Livny, D. Ben-Menahem, and T. Gudermann
A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation
J. Mol. Endocrinol., February 1, 2007; 38(2): 259 - 275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Galet and M. Ascoli
A Constitutively Active Mutant of the Human Lutropin Receptor (hLHR-L457R) Escapes Lysosomal Targeting and Degradation
Mol. Endocrinol., November 1, 2006; 20(11): 2931 - 2945.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, D. Mizrachi, F. Fanelli, and D. L. Segaloff
The Formation of a Salt Bridge Between Helices 3 and 6 Is Responsible for the Constitutive Activity and Lack of Hormone Responsiveness of the Naturally Occurring L457R Mutation of the Human Lutropin Receptor
J. Biol. Chem., July 15, 2005; 280(28): 26169 - 26176.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Hirakawa and M. Ascoli
A Constitutively Active Somatic Mutation of the Human Lutropin Receptor Found in Leydig Cell Tumors Activates the Same Families of G Proteins as Germ Line Mutations Associated with Leydig Cell Hyperplasia
Endocrinology, September 1, 2003; 144(9): 3872 - 3878.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Shinozaki, V. Butnev, Y.-X. Tao, K. L. Ang, M. Conti, and D. L. Segaloff
Desensitization of Gs-Coupled Receptor Signaling by Constitutively Active Mutants of the Human Lutropin/Choriogonadotropin Receptor
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1194 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Ascoli, F. Fanelli, and D. L. Segaloff
The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Endocr. Rev., April 1, 2002; 23(2): 141 - 174.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Hirakawa, C. Galet, and M. Ascoli
MA-10 Cells Transfected with the Human Lutropin/Choriogonadotropin Receptor (hLHR): A Novel Experimental Paradigm to Study the Functional Properties of the hLHR
Endocrinology, March 1, 2002; 143(3): 1026 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Shinozaki, F. Fanelli, X. Liu, J. Jaquette, K. Nakamura, and D. L. Segaloff
Pleiotropic Effects of Substitutions of a Highly Conserved Leucine in Transmembrane Helix III of the Human Lutropin/Choriogonadotropin Receptor with Respect to Constitutive Activation and Hormone Responsiveness
Mol. Endocrinol., June 1, 2001; 15(6): 972 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. C. Latronico, H. Shinozaki, G. Guerra Jr., M. A. A. Pereira, S. H. V. Lemos Marini, M. T. M. Baptista, I. J. P. Arnhold, F. Fanelli, B. B. Mendonca, and D. L. Segaloff
Gonadotropin-Independent Precocious Puberty Due to Luteinizing Hormone Receptor Mutations in Brazilian Boys: A Novel Constitutively Activating Mutation in the First Transmembrane Helix
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4799 - 4805.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
L. Min and M. Ascoli
Effect of Activating and Inactivating Mutations on the Phosphorylation and Trafficking of the Human Lutropin/Choriogonadotropin Receptor
Mol. Endocrinol., November 1, 2000; 14(11): 1797 - 1810.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
Y.-X. Tao, A. N. Abell, X. Liu, K. Nakamura, and D. L. Segaloff
Constitutive Activation of G Protein-Coupled Receptors as a Result of Selective Substitution of a Conserved Leucine Residue in Transmembrane Helix III
Mol. Endocrinol., August 1, 2000; 14(8): 1272 - 1282.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
K. Nakamura, M. d. F. M. Lazari, S. Li, C. Korgaonkar, and M. Ascoli
Role of the Rate of Internalization of the Agonist-Receptor Complex on the Agonist-Induced Down-Regulation of the Lutropin/ Choriogonadotropin Receptor
Mol. Endocrinol., August 1, 1999; 13(8): 1295 - 1304.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K.-S. Min, X. Liu, J. Fabritz, J. Jaquette, A. N. Abell, and M. Ascoli
Mutations That Induce Constitutive Activation and Mutations That Impair Signal Transduction Modulate the Basal and/or Agonist-stimulated Internalization of the Lutropin/Choriogonadotropin Receptor
J. Biol. Chem., December 25, 1998; 273(52): 34911 - 34919.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. N. Abell, D. J. McCormick, and D. L. Segaloff
Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs
Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Min, C. Galet, and M. Ascoli
The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor Phosphorylation
J. Biol. Chem., January 4, 2002; 277(1): 702 - 710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society